C. García-Martos, A. M. Alonso, E. Martínez, S. Monge, J. Sánchez de la Mata, M. J. Sierra, R. Rodríguez Fernández

RSV surveillance is essential because of its impact in young children and older adults. Since 2023/24, passive immunization with nirsevimab has been recommended for infants under 6 months at the start of the RSV season or born during it and for high-risk older children.
Weekly time series of severe RSV hospitalization incidence per 100000 inhabitants are analyzed from 2022/23 to 2025/26 in 5 Spanish Autonomous Communities, covering over 55% of the population. 8 age groups are considered, focusing on <1, 1-4 and >60 years.
We use Dynamic Factor Models to compare forecasting strategies: modelling all age groups within each region versus jointly modelling each age group across regions. Preliminary results show high synchrony across regions in <1-year incidence, with one common factor explaining over 99% of the variability, supporting joint multiregional forecasting. More accurate predictions may help in decision making about healthcare planning and resource management during RSV seasons.

Keywords: Forecasting, Multivariate Time Series, Dimensionality reduction, SDG, Respiratory infection

Scheduled

SI Statistics and the Sustainable Development Goals (SDGs): Methodological Approaches and Applications in Health, Climate Action, and Energy
September 3, 2026  9:00 AM
Aula 30


Other papers in the same session


Cookie policy

We use cookies in order to be able to identify and authenticate you on the website. They are necessary for the correct functioning of it, and therefore they can not be disabled. If you continue browsing the website, you are agreeing with their acceptance, as well as our Privacy Policy.

Additionally, we use Google Analytics in order to analyze the website traffic. They also use cookies and you can accept or refuse them with the buttons below.

You can read more details about our Cookie Policy and our Privacy Policy.